{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:15:47Z","timestamp":1790748947219,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":3663,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P21173-B13"],"award-info":[{"award-number":["P21173-B13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ajpath.2011.01.020","type":"journal-article","created":{"date-parts":[[2011,4,24]],"date-time":"2011-04-24T20:21:54Z","timestamp":1303676514000},"page":"2344-2356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Identification of Oncostatin M as a STAT5-Dependent Mediator of Bone Marrow Remodeling in KIT D816V-Positive Systemic Mastocytosis"],"prefix":"10.1016","volume":"178","author":[{"given":"Gregor","family":"Hoermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Cerny-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pern\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Klauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Hoetzenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M.B.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mayerhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.01.020_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.med.55.091902.103822","article-title":"Systemic mastocytosis","volume":"55","author":"Akin","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajpath.2011.01.020_bib2","series-title":"World Health Organization Classification of Tumours","first-page":"291","article-title":"Mastocytosis (mast cell disease)","author":"Valent","year":"2001"},{"key":"10.1016\/j.ajpath.2011.01.020_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","article-title":"Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings","volume":"25","author":"Horny","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.ajpath.2011.01.020_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000048182","article-title":"Mastocytosis and fibrosis: role of cytokines","volume":"127","author":"Li","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0002-9440(10)61111-X","article-title":"Increased angiogenesis in the bone marrow of patients with systemic mastocytosis","volume":"160","author":"Wimazal","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib6","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1073\/pnas.86.24.10039","article-title":"Development of human mast cells in vitro","volume":"86","author":"Furitsu","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib7","first-page":"136","article-title":"Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts","volume":"77","author":"Irani","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.ajpath.2011.01.020_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/cimm.1995.1071","article-title":"Human foreskin mast cell viability and functional activity is maintained ex vivo by coculture with fibroblasts","volume":"162","author":"Levi-Schaffer","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4049\/jimmunol.172.1.260","article-title":"Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor","volume":"172","author":"Sellge","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib10","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation","volume":"202","author":"Zappulla","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2011.01.020_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V98.5.1365","article-title":"Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant","volume":"98","author":"Chian","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib15","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","article-title":"Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens","volume":"180","author":"Mayerhofer","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib16","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1073\/pnas.93.25.14665","article-title":"Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1","volume":"93","author":"Piao","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib17","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2002-11-3490","article-title":"Stat5 expression is critical for mast cell development and survival","volume":"102","author":"Shelburne","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.2007.06708.x","article-title":"Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation","volume":"139","author":"Zuluaga Toro","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib19","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","article-title":"Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis","volume":"175","author":"Baumgartner","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0024-3205(99)00296-9","article-title":"Oncostatin M: signal transduction and biological activity","volume":"65","author":"G\u00f3mez-Lech\u00f3n","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.ajpath.2011.01.020_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor","volume":"255","author":"Gearing","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.01.020_bib22","first-page":"61","article-title":"Oncostatin M binds the high-affinity leukemia inhibitory factor receptor","volume":"4","author":"Gearing","year":"1992","journal-title":"New Biol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib23","doi-asserted-by":"crossref","first-page":"32635","DOI":"10.1074\/jbc.271.51.32635","article-title":"Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation","volume":"271","author":"Mosley","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.01.020_bib24","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1161\/01.ATV.19.8.1835","article-title":"Oncostatin M induces angiogenesis in vitro and in vivo","volume":"19","author":"Vasse","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib26","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0704769","article-title":"Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts","volume":"136","author":"Scaffidi","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1359\/jbmr.1998.13.5.793","article-title":"Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines","volume":"13","author":"Jilka","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ajpath.2011.01.020_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1006\/cyto.2000.0747","article-title":"gp130 Cytokine family and bone cells","volume":"12","author":"Heymann","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.ajpath.2011.01.020_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1532\/IJH97.06090","article-title":"Oncostatin M maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow","volume":"84","author":"Minehata","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib30","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2003-02-0367","article-title":"Targeted disruption of oncostatin M receptor results in altered hematopoiesis","volume":"102","author":"Tanaka","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10254-003-0013-1","article-title":"Oncostatin M, a multifunctional cytokine","volume":"149","author":"Tanaka","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib32","first-page":"17","article-title":"PKC412\u2014a protein kinase inhibitor with a broad therapeutic potential","volume":"15","author":"Fabbro","year":"2000","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.ajpath.2011.01.020_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.ajpath.2011.01.020_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0301-472X(03)00112-7","article-title":"Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit","volume":"31","author":"Akin","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1346-8138.1994.tb03300.x","article-title":"Pharmacological modulation of endothelial cell-associated adhesion molecule expression: implications for future treatment of dermatological diseases","volume":"21","author":"Foster","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","article-title":"HMEC-1: establishment of an immortalized human microvascular endothelial cell line","volume":"99","author":"Ades","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib37","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood.V73.7.1778.1778","article-title":"Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes","volume":"73","author":"Valent","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib38","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","article-title":"Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein","volume":"85","author":"Daley","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2011.01.020_bib39","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1182\/blood-2007-07-102848","article-title":"Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2","volume":"111","author":"Grebien","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni1172","article-title":"STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression","volume":"6","author":"Scheeren","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib41","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2006-11-055723","article-title":"Targeting of heat shock protein 32 (Hsp32)\/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib","volume":"111","author":"Mayerhofer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib42","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/j.1460-2075.1996.tb00443.x","article-title":"Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway","volume":"15","author":"Yoshimura","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2011.01.020_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0898-6568(98)00049-7","article-title":"Role of STAT5 in interferon-alpha signal transduction in Ba\/F3 cells","volume":"11","author":"Jaster","year":"1999","journal-title":"Cell Signal"},{"key":"10.1016\/j.ajpath.2011.01.020_bib44","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1074\/jbc.275.17.12661","article-title":"Distinct mechanisms of STAT phosphorylation via the interferon-alpha\/beta receptor: selective inhibition of STAT3 and STAT5 by piceatannol","volume":"275","author":"Su","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2011.01.020_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2007.08.054","article-title":"Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance","volume":"121","author":"Salamon","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib46","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1182\/blood.V86.4.1310.bloodjournal8641310","article-title":"Thrombocytopoietic properties of oncostatin M","volume":"86","author":"Wallace","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI25227","article-title":"Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis","volume":"116","author":"Menon","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.01.020_bib48","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0161-5890(02)00061-5","article-title":"Stat5: an essential regulator of mast cell biology","volume":"38","author":"Shelburne","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib49","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.177.5.3421","article-title":"Stat5 expression is required for IgE-mediated mast cell function","volume":"177","author":"Barnstein","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2011.01.020_bib50","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood-2007-09-115477","article-title":"Oncogenic Kit controls neoplastic mast cell growth through a Stat5\/PI3-kinase signaling cascade","volume":"112","author":"Harir","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2011.01.020_bib51","doi-asserted-by":"crossref","first-page":"e7989","DOI":"10.1371\/journal.pone.0007989","article-title":"Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses","volume":"4","author":"Han","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2011.01.020_bib52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/PL00007465","article-title":"The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice","volume":"293","author":"Gyotoku","year":"2001","journal-title":"Arch Dermatol Res"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011001295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011001295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:58:54Z","timestamp":1762081134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011001295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0002944011001295"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.020","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Oncostatin M as a STAT5-Dependent Mediator of Bone Marrow Remodeling in KIT D816V-Positive Systemic Mastocytosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}